Trial Profile
Phase II study of bevacizumab combined with oral leucovorin plus UFT for elderly patients with metastatic colorectal cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Apr 2019
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Folinic acid; Tegafur/uracil
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms J-BLUE study
- 11 Dec 2015 New trial record